LEUKEMIA, MYELOID, ACUTE
Clinical trials for LEUKEMIA, MYELOID, ACUTE explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOID, ACUTE trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOID, ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for older, frailer leukemia patients in major drug trial
Disease control OngoingThis study is testing whether adding a new drug called AG-120 (ivosidenib) to standard chemotherapy (azacitidine) works better than the standard chemo alone for adults with a specific type of newly diagnosed acute myeloid leukemia (AML). It is for patients aged 18 and older who a…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE3 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for Tough-to-Treat leukemia: early trial tests novel drug combo
Disease control OngoingThis early-stage study is testing a new drug called bleximenib in combination with standard treatments for acute myeloid leukemia (AML) that has specific genetic changes. The main goals are to find the safest and most effective dose and to see how well patients tolerate the combi…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Pill aims to keep deadly blood cancer at bay after initial treatment
Disease control OngoingThis study is testing whether adding a pill called oral azacitidine to standard care can help keep acute myeloid leukemia (AML) from coming back in Chinese patients who have achieved remission. It will compare the pill plus standard care against standard care alone. The main goal…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Targeted attack on blood cancer offers hope for frail patients
Disease control OngoingThis study is testing two new drug combinations for adults newly diagnosed with a specific genetic type of acute myeloid leukemia (AML) who are not healthy enough for standard intensive chemotherapy. The goal is to find safe and effective doses and see if adding a new targeted pi…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE1, PHASE2 • Sponsor: Celgene • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Can music and mindfulness ease the hardship of a stem cell transplant?
Symptom relief OngoingThis study is testing a new electronic program that combines mindfulness and music therapy. It aims to help patients feel better and manage symptoms during and after a difficult stem cell transplant for blood cancers. The research will see if this program improves quality of life…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC
-
Cancer drug safety watch: tracking Long-Term effects
Knowledge-focused ENROLLING_BY_INVITATIONThis study tracks the long-term safety of experimental cancer treatments in patients who previously participated in earlier Janssen trials. It follows 80 people with various cancers to monitor for serious side effects over time. The goal is to better understand the safety profile…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:54 UTC